Literature DB >> 28420743

Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine.

Ji Zhang1, Natalya N Pavlova1, Craig B Thompson2.   

Abstract

Biochemistry textbooks and cell culture experiments seem to be telling us two different things about the significance of external glutamine supply for mammalian cell growth and proliferation. Despite the fact that glutamine is a nonessential amino acid that can be synthesized by cells from glucose-derived carbons and amino acid-derived ammonia, most mammalian cells in tissue culture cannot proliferate or even survive in an environment that does not contain millimolar levels of glutamine. Not only are the levels of glutamine in standard tissue culture media at least ten-fold higher than other amino acids, but glutamine is also the most abundant amino acid in the human bloodstream, where it is assiduously maintained at approximately 0.5 mM through a combination of dietary uptake, de novo synthesis, and muscle protein catabolism. The complex metabolic logic of the proliferating cancer cells' appetite for glutamine-which goes far beyond satisfying their protein synthesis requirements-has only recently come into focus. In this review, we examine the diversity of biosynthetic and regulatory uses of glutamine and their role in proliferation, stress resistance, and cellular identity, as well as discuss the mechanisms that cells utilize in order to adapt to glutamine limitation.
© 2017 The Authors.

Entities:  

Keywords:  cancer; glutamine metabolism; proliferation; stress response

Mesh:

Substances:

Year:  2017        PMID: 28420743      PMCID: PMC5430235          DOI: 10.15252/embj.201696151

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  129 in total

1.  The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation.

Authors:  Jiangbin Ye; Monika Kumanova; Lori S Hart; Kelly Sloane; Haiyan Zhang; Diego N De Panis; Ekaterina Bobrovnikova-Marjon; J Alan Diehl; David Ron; Constantinos Koumenis
Journal:  EMBO J       Date:  2010-05-14       Impact factor: 11.598

2.  L-asparaginase in the treatment of neoplastic diseases in children.

Authors:  N Jaffe; D Traggis; L Das; W C Moloney; H W Hann; B S Kim; R Nair
Journal:  Cancer Res       Date:  1971-07       Impact factor: 12.701

3.  Prognostic significance of glutamine synthetase expression in unifocal advanced hepatocellular carcinoma.

Authors:  T Osada; I Nagashima; N H Tsuno; J Kitayama; H Nagawa
Journal:  J Hepatol       Date:  2000-08       Impact factor: 25.083

Review 4.  Inborn error of amino acid synthesis: human glutamine synthetase deficiency.

Authors:  Johannes Häberle; Boris Görg; Annick Toutain; Frank Rutsch; Jean-François Benoist; Antoinette Gelot; Annie-Laure Suc; Hans Georg Koch; Freimut Schliess; Dieter Häussinger
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

5.  Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1.

Authors:  Issam Ben-Sahra; Jessica J Howell; John M Asara; Brendan D Manning
Journal:  Science       Date:  2013-02-21       Impact factor: 47.728

6.  ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation.

Authors:  Guoliang Qing; Bo Li; Annette Vu; Nicolas Skuli; Zandra E Walton; Xueyuan Liu; Patrick A Mayes; David R Wise; Craig B Thompson; John M Maris; Michael D Hogarty; M Celeste Simon
Journal:  Cancer Cell       Date:  2012-11-13       Impact factor: 31.743

Review 7.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

Authors:  P Vaupel; F Kallinowski; P Okunieff
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

8.  Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping.

Authors:  Darrell R Borger; Kenneth K Tanabe; Kenneth C Fan; Hector U Lopez; Valeria R Fantin; Kimberly S Straley; David P Schenkein; Aram F Hezel; Marek Ancukiewicz; Hannah M Liebman; Eunice L Kwak; Jeffrey W Clark; David P Ryan; Vikram Deshpande; Dora Dias-Santagata; Leif W Ellisen; Andrew X Zhu; A John Iafrate
Journal:  Oncologist       Date:  2011-12-16       Impact factor: 5.837

9.  Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer.

Authors:  Moloy T Goswami; Guoan Chen; Balabhadrapatruni V S K Chakravarthi; Satya S Pathi; Sharath K Anand; Shannon L Carskadon; Thomas J Giordano; Arul M Chinnaiyan; Dafydd G Thomas; Nallasivam Palanisamy; David G Beer; Sooryanarayana Varambally
Journal:  Oncotarget       Date:  2015-09-15

10.  Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target.

Authors:  Luika A Timmerman; Thomas Holton; Mariia Yuneva; Raymond J Louie; Mercè Padró; Anneleen Daemen; Min Hu; Denise A Chan; Stephen P Ethier; Laura J van 't Veer; Kornelia Polyak; Frank McCormick; Joe W Gray
Journal:  Cancer Cell       Date:  2013-10-03       Impact factor: 31.743

View more
  187 in total

1.  The phosphatidylethanolamine biosynthesis pathway provides a new target for cancer chemotherapy.

Authors:  Yuan Guan; Xinyu Chen; Manhong Wu; Wan Zhu; Ahmed Arslan; Saori Takeda; Mindie H Nguyen; Ravindra Majeti; Dan Thomas; Ming Zheng; Gary Peltz
Journal:  J Hepatol       Date:  2019-11-22       Impact factor: 25.083

Review 2.  The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance.

Authors:  Douglas E Biancur; Alec C Kimmelman
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-04-24       Impact factor: 10.680

Review 3.  Microenvironmental Metabolism Regulates Antitumor Immunity.

Authors:  Verra M Ngwa; Deanna N Edwards; Mary Philip; Jin Chen
Journal:  Cancer Res       Date:  2019-07-30       Impact factor: 12.701

4.  Glutamine Metabolism Regulates Proliferation and Lineage Allocation in Skeletal Stem Cells.

Authors:  Yilin Yu; Hunter Newman; Leyao Shen; Deepika Sharma; Guoli Hu; Anthony J Mirando; Hongyuan Zhang; Everett Knudsen; Guo-Fang Zhang; Matthew J Hilton; Courtney M Karner
Journal:  Cell Metab       Date:  2019-02-14       Impact factor: 27.287

5.  Glutaminase GLS1 senses glutamine availability in a non-enzymatic manner triggering mitochondrial fusion.

Authors:  Wei-Feng Cai; Cixiong Zhang; Yu-Qing Wu; Gui Zhuang; Zhiyun Ye; Chen-Song Zhang; Sheng-Cai Lin
Journal:  Cell Res       Date:  2018-06-22       Impact factor: 25.617

6.  Heme, whence come thy carbon building blocks?

Authors:  Tracey A Rouault
Journal:  Blood       Date:  2018-09-06       Impact factor: 22.113

Review 7.  Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine.

Authors:  Ji Zhang; Natalya N Pavlova; Craig B Thompson
Journal:  EMBO J       Date:  2017-04-18       Impact factor: 11.598

8.  Deletion of Neuronal GLT-1 in Mice Reveals Its Role in Synaptic Glutamate Homeostasis and Mitochondrial Function.

Authors:  Laura F McNair; Jens V Andersen; Blanca I Aldana; Michaela C Hohnholt; Jakob D Nissen; Yan Sun; Kathryn D Fischer; Ursula Sonnewald; Nils Nyberg; Sophie C Webster; Kush Kapur; Theresa S Rimmele; Ilaria Barone; Hannah Hawks-Mayer; Jonathan O Lipton; Nathaniel W Hodgson; Takao K Hensch; Chiye J Aoki; Paul A Rosenberg; Helle S Waagepetersen
Journal:  J Neurosci       Date:  2019-03-29       Impact factor: 6.167

Review 9.  The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension.

Authors:  Thomas Bertero; Dror Perk; Stephen Y Chan
Journal:  Expert Opin Ther Targets       Date:  2019-05-11       Impact factor: 6.902

10.  Complementary α-arrestin-ubiquitin ligase complexes control nutrient transporter endocytosis in response to amino acids.

Authors:  Vasyl Ivashov; Johannes Zimmer; Sinead Schwabl; Jennifer Kahlhofer; Sabine Weys; Ronald Gstir; Thomas Jakschitz; Leopold Kremser; Günther K Bonn; Herbert Lindner; Lukas A Huber; Sebastien Leon; Oliver Schmidt; David Teis
Journal:  Elife       Date:  2020-08-03       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.